drugset / Trial / NCT00929734
Effect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary Disease
Phase 2
Completed
99 enrolled
University Hospital, Akershus
AstraZeneca · collabHaukeland University Hospital · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to investigate whether rosuvastatin improves measures of endothelial function, decreases measures of inflammation, and improves pulmonary function in patients with stable chronic obstructive pulmonary disease.
Timeline
- Start
- 2010-03
- Primary completion
- 2014-01
- Completion
- 2014-01
Outcome
Missed primary endpoint
registry analysis (superiority or other test); Rosuvastatin vs Placebo; p = 0.292; ANCOVA NCT00929734 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 10 mg | — |